Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During US-guided Transbronchial Needle Aspiration (EBUS-TBNA): a Randomized, Prospective, Control Study

NCT06033729 is registered in ClinicalTrials.gov with Scarlata, Simone, M.D. as lead sponsor.

NCT NCT06033729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06033729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During US-guided Transbronchial Needle Aspiration (EBUS-TBNA): a Randomized, Prospective, Control Study
Lead sponsor
Scarlata, Simone, M.D.
Phase
Not applicable
Overall status
Completed
Start date
September 20, 2021
Completion date
January 17, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endoscopy, lung cancer, lung; node, sedation complication